SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
How did the stock prices of Sanofi and Teva react to the positive results of the RELIEVE UCCD study? Sanofi stock rose nearly 7% and Teva jumped 26%, even hitting a six-year high of 21.05. Year to date, Sanofi's stock fell 1.6% against the industry's 5.3% growth, while Teva's stock has doubled in market value compared with the industry's 11.2% growth. Was this helpful? Yes No What were the results of the phase IIb RELIEVE UCCD study on Sanofi and Teva's investigational anti-TL1A therapy, duvakitug, for the treatment of Ulcerative Colitis (UC) and Crohn's disease (CD)? The study met its primary endpoints for both diseases. In the UC group, 36.2% of patients who received a low dose of the drug and 47.8% of patients who received a high dose achieved clinical remission compared to 20.45% for placebo. For the CD group, 26.1% of patients who received a low dose and 47.8% of patients who took a high dose achieved endoscopic response compared to 13% in the placebo group. Was th
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Model N Achieves ISO/IEC 27001 Certification, the Global Standard for Information Security [Yahoo! Finance]Yahoo! Finance
- Why Is Johnson & Johnson (JNJ) Among the Best Dividend Stocks to Invest In? [Yahoo! Finance]Yahoo! Finance
- Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA [Yahoo! Finance]Yahoo! Finance
- Why Long-Form Entertainment Can Be A Content Marketer’s Biggest Gift: USPS’s Dear Santa Franchise [Forbes]Forbes
- Innovating With Purpose: Johnson & Johnson’s Mission To Develop Targeted Treatments For Autoantibody Diseases [Forbes]Forbes
JNJ
Earnings
- 10/15/24 - Beat
JNJ
Sec Filings
- 12/12/24 - Form 4
- 12/12/24 - Form 4
- 12/12/24 - Form 4
- JNJ's page on the SEC website